DK379782A - Fremgangsmaade til fremstilling af guaninforbindelser og mellemprodukter til brug ved udoevelse af fremgangsmaaden - Google Patents

Fremgangsmaade til fremstilling af guaninforbindelser og mellemprodukter til brug ved udoevelse af fremgangsmaaden Download PDF

Info

Publication number
DK379782A
DK379782A DK379782A DK379782A DK379782A DK 379782 A DK379782 A DK 379782A DK 379782 A DK379782 A DK 379782A DK 379782 A DK379782 A DK 379782A DK 379782 A DK379782 A DK 379782A
Authority
DK
Denmark
Prior art keywords
compounds
procedure
guane
exercising
intermediates
Prior art date
Application number
DK379782A
Other languages
Danish (da)
English (en)
Inventor
Wallace T Ashton
Arthur K Field
John D Karkas
Richard L Tolman
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of DK379782A publication Critical patent/DK379782A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
DK379782A 1981-08-26 1982-08-25 Fremgangsmaade til fremstilling af guaninforbindelser og mellemprodukter til brug ved udoevelse af fremgangsmaaden DK379782A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29660481A 1981-08-26 1981-08-26

Publications (1)

Publication Number Publication Date
DK379782A true DK379782A (da) 1983-02-27

Family

ID=23142740

Family Applications (1)

Application Number Title Priority Date Filing Date
DK379782A DK379782A (da) 1981-08-26 1982-08-25 Fremgangsmaade til fremstilling af guaninforbindelser og mellemprodukter til brug ved udoevelse af fremgangsmaaden

Country Status (14)

Country Link
EP (1) EP0074306B1 (xx)
JP (3) JPS5877881A (xx)
KR (1) KR840001168A (xx)
AT (1) ATE34750T1 (xx)
AU (1) AU8755282A (xx)
CA (1) CA1300622C (xx)
DE (1) DE3278561D1 (xx)
DK (1) DK379782A (xx)
ES (2) ES8402837A1 (xx)
GR (1) GR76861B (xx)
IL (1) IL66640A0 (xx)
NZ (1) NZ201662A (xx)
PT (1) PT75463B (xx)
ZA (1) ZA826196B (xx)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5157120A (en) * 1980-09-16 1992-10-20 Syntex (U.S.A.) Inc. Guanine derivatives
US4347360A (en) * 1980-09-16 1982-08-31 Ens Bio Logicals Inc. Ring open nucleoside analogues
ES8403128A1 (es) * 1981-08-11 1983-10-01 Wellcome Found "un procedimiento para preparar derivados de purina".
US4816447A (en) * 1981-08-26 1989-03-28 Merck & Co., Inc. Anti-viral guanine compounds
US5250535A (en) * 1982-02-01 1993-10-05 Syntex Inc. Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) purines as antiviral agent
JPS58135885A (ja) * 1982-02-01 1983-08-12 シンテツクス(ユ−・エス・エイ)インコ−ポレイテツド 置換されたプリン、その製造方法およびそれからなる抗ウイルス剤
US4556659A (en) * 1982-08-09 1985-12-03 Syntex (U.S.A.) Inc. Substituted 9-(1-0- or 3-0-monosubstituted or 1,3-Di-0-substituted propoxymethyl)-purines as antiviral agents
EP0105486A3 (en) * 1982-09-30 1984-05-16 Syntex (U.S.A.) Inc. 1-monophosphate esters, 1,3-bisphosphate esters and cyclic phosphate esters of 9-(1,3-dihydroxy-2-propoxymethyl)-guanine as antiviral agents
US4609662A (en) * 1982-10-14 1986-09-02 Burroughs Wellcome Co. Method for using purine derivatives
US4544634A (en) * 1982-10-14 1985-10-01 Burroughs Wellcome Co. Method of producing acyclovir
US4462986A (en) * 1982-11-04 1984-07-31 Ens Bio Logicals, Inc. Synergistic anti-herpes compositions
US5047533A (en) * 1983-05-24 1991-09-10 Sri International Acyclic purine phosphonate nucleotide analogs
GB2150570B (en) * 1983-05-24 1987-04-08 Stanford Res Inst Int Novel antiviral agents
IL72173A0 (en) * 1983-06-24 1984-10-31 Merck & Co Inc Guanine derivatives,their preparation and pharmaceutical compositions containing them
JPS6023380A (ja) * 1983-06-24 1985-02-05 メルク・エンド・カムパニー・インコーポレーテッド 抗ウイルス剤
US4880820A (en) * 1983-06-24 1989-11-14 Merck & Co., Inc. Guanine derivatives
US4670424A (en) * 1983-09-19 1987-06-02 Merck & Co., Inc. Cyclic pyrophosphates of purine and pyrimidine acyclonucleosides
US4897479A (en) * 1983-09-30 1990-01-30 Merck & Co., Inc. Arylsulfonyloxy purine intermediates
EP0138683A3 (en) * 1983-09-30 1988-01-20 Merck & Co. Inc. Purine derivatives, their application in anti-viral compositions
IL73682A (en) * 1983-12-20 1991-08-16 Medivir Ab Antiviral pharmaceutical compositions containing 9-hydroxy aliphatic derivatives of guanine,some new such derivatives and process for their preparation
DE3571810D1 (en) * 1984-01-26 1989-08-31 Merck & Co Inc Substituted butyl guanines and their utilization in antiviral compositions
US4579849A (en) * 1984-04-06 1986-04-01 Merck & Co., Inc. N-alkylguanine acyclonucleosides as antiviral agents
EP0184473A1 (en) * 1984-10-26 1986-06-11 Merck & Co. Inc. Regioselective synthesis of 9-substituted purine acyclonucleoside derivatives
HUT39145A (en) * 1984-12-12 1986-08-28 Syntex Inc Process for preparing alkoxy-methyl-ether and alkoxy-methyl ester derivatives
SE8406538D0 (sv) 1984-12-21 1984-12-21 Astra Laekemedel Ab Novel derivatives of purine
CA1330794C (en) * 1987-03-27 1994-07-19 Phillip Frost Anti-viral compounds, dosage forms and methods
US4966895A (en) * 1989-02-02 1990-10-30 Merck & Co. Inc. Cyclic monophosphates of purine and pyrimidine acyclonucleosides as anti-retroviral agents
US5068119A (en) * 1990-09-28 1991-11-26 Nabisco Brands, Inc. Acid-hydrolyzable ester derivatives as low calorie fat mimetics
GB2260319B (en) 1991-10-07 1995-12-06 Norsk Hydro As Acyl derivatives of nucleosides and nucleoside analogues having anti-viral activity
US5532225A (en) * 1992-07-31 1996-07-02 Sri International Acyclic purine phosphonate nucleotide analogs as antiviral agents, and related synthetic methods
US5565565A (en) * 1994-08-04 1996-10-15 Syntex (U.S.A.) Inc. Preparation of N-9 substituted guanine compounds
US5840890A (en) * 1996-01-26 1998-11-24 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
CN1091445C (zh) * 1999-12-29 2002-09-25 湖北省医药工业研究院 抗病毒药物中间体、它们的制备及应用
EP1565470A2 (en) * 2002-10-31 2005-08-24 Ranbaxy Laboratories Limited Process for the preparation of ganciclovir
CN113024559B (zh) * 2019-12-25 2022-03-29 上药康丽(常州)药业有限公司 一种异更昔洛韦的制备方法
KR20240077879A (ko) * 2022-11-25 2024-06-03 롯데케미칼 주식회사 올레핀 올리고머화의 부산물 저감 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4146715A (en) * 1975-08-27 1979-03-27 Burroughs Wellcome Co. 2-amido-9-(2-acyloxyethoxymethyl)hypoxanthines
US4347360A (en) * 1980-09-16 1982-08-31 Ens Bio Logicals Inc. Ring open nucleoside analogues
US4355032B2 (en) * 1981-05-21 1990-10-30 9-(1,3-dihydroxy-2-propoxymethyl)guanine as antiviral agent
ES8403128A1 (es) * 1981-08-11 1983-10-01 Wellcome Found "un procedimiento para preparar derivados de purina".
JPS58135885A (ja) * 1982-02-01 1983-08-12 シンテツクス(ユ−・エス・エイ)インコ−ポレイテツド 置換されたプリン、その製造方法およびそれからなる抗ウイルス剤

Also Published As

Publication number Publication date
EP0074306A2 (en) 1983-03-16
JPH04217940A (ja) 1992-08-07
ES522456A0 (es) 1984-08-01
JPS5877881A (ja) 1983-05-11
ES515193A0 (es) 1984-03-01
ES8402837A1 (es) 1984-03-01
GR76861B (xx) 1984-09-04
ES8406547A1 (es) 1984-08-01
DE3278561D1 (en) 1988-07-07
NZ201662A (en) 1986-07-11
EP0074306B1 (en) 1988-06-01
PT75463B (en) 1986-08-28
CA1300622C (en) 1992-05-12
IL66640A0 (en) 1982-12-31
ZA826196B (en) 1984-04-25
JPH05286974A (ja) 1993-11-02
JPH0729979B2 (ja) 1995-04-05
PT75463A (en) 1982-09-01
JPH0480914B2 (xx) 1992-12-21
ATE34750T1 (de) 1988-06-15
AU8755282A (en) 1983-03-03
KR840001168A (ko) 1984-03-28
JPH0714938B2 (ja) 1995-02-22
EP0074306A3 (en) 1983-05-25

Similar Documents

Publication Publication Date Title
DK379782A (da) Fremgangsmaade til fremstilling af guaninforbindelser og mellemprodukter til brug ved udoevelse af fremgangsmaaden
NO155055C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive beta-carbolin-3-carboxylsyrederivater.
DK359082A (da) Fremgangsmaade til fremstilling af antivirale purinderivater eller fysiologisk acceptable salte eller estere deraf
DK159444C (da) Analogifremgangsmaade til fremstilling af derivater af 9-(2-hydroxyethoxymethyl)guanin
NO156690C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive indanderivater.
ATE10368T1 (de) Uracilderivate, verfahren zu ihrer herstellung und eine diese enthaltende pharmazeutische zubereitung.
OA06563A (fr) Procédé de préparation de nouveaux dérivés d'indolizine.
AR215271A1 (es) Un procedimiento para la preparacion de derivados de 1,2-benzoisotiazol-3-ona y una sal de adicion acida farmaceuticamente aceptable
NO792139L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazoloksamsyre-derivater
ES2037095T3 (es) Un procedimiento para preparar una composicion farmaceutica.
NO790394L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alkanolaminderivater
FR2318137A1 (fr) Procede de preparation d'ethers perfluores par irradiation lumineuse de perfluoro-cetones
NO143907C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive pyrrolo(1,2-a)-imidazol-derivater
FR2532647B1 (fr) Thioesters d'acide acetylsalicylique, procede pour les preparer et compositions pharmaceutiques qui en renferment
ES456407A1 (es) Un metodo de preparacion de una purina sustituida.
OA06310A (fr) Nouveaux dérivés N-substitués de l'acide aziridinyl-2-carboxylique et leur procédé de préparation.
PT76903A (en) Process for preparing novel derivatives of guanine and of pharmaceutical compositions containing the same
FR2319644A1 (fr) Procede de preparation du sodium benzyle, de l'acide phenylacetique et de derives de celui-ci
ATE23856T1 (de) Derivate der d-2-(6-methoxy-2-naphthyl)propions|ure mit therapeutischer wirkung, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate.
BE845532A (fr) Procede de preparation d'aminoacetaldehyde acetals
ZA88640B (en) Novel imidazo-and triazolothiadiazines,a process for the preparation thereof,medicaments containing same,and the use thereof,and some intermediates formed in the preparation of the compounds mentioned
BE861325A (fr) Nouveaux ethers de l'acide clavulanique, utilisables comme medicaments
FR2375184A1 (fr) Nouveaux derives de l'acide benzoyl phenoxy acetique, leur procede de preparation et leur application en therapeutique
AR220133Q (es) Procedimiento de obtencion de preparaciones solidas de medicamentos muy poco solubles,al estado muy finamente dividido
BE837624A (fr) Procede de preparation de derives de l'acide alpha-phenyl-propionique

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment